Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
Inventors
Levine, Jacob A. • Faltys, Michael A.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Described herein are methods and systems for using EEG recordings to improve vagus nerve stimulation (VNS) therapy. In particular, described herein are methods and systems for using EEG recordings to detect P300 and/or activation of the nucleus basalis and/or the locus coeruleus to determine the efficacy of VNS. The EEG recordings can be used to provide feedback control to help optimize stimulation parameters and to screen for patients that respond well to VNS therapy.
Core Innovation
The disclosed system includes an implantable nerve stimulator, an EEG recording device, and a controller in communication with both devices. The controller determines from the EEG whether P300 is present or the nucleus basalis or locus coeruleus is activated, and adjusts programmed stimulation parameters based on that determination. The system decreases stimulation settings when an indicated response is present and increases them when an indication is absent.
The system performs EEG-guided adjustment with repeated EEG assessment, adjusting stimulation based on target-region activation or marker thresholds. Stimulation parameters are repeatedly adjusted until the dose reaches a level necessary, or the minimum level necessary, to modulate a patient's inflammatory reflex. The disclosure also describes EEG-based prescreening for vagus nerve stimulation response, while the problem being solved is not explicitly stated.
Claims Coverage
The provided relevant claims include five independent claims: claims 1, 9, 10, 17, and 18. They cover EEG-guided control of an implantable nerve stimulator, with conditional increases or decreases in stimulation settings and repeated adjustment toward a dose that modulates an inflammatory reflex.
EEG-indicated response with decreased stimulation
Claim 1 covers an implantable nerve stimulator, an EEG recording device, and a controller that determines whether P300 is present or the nucleus basalis or locus coeruleus is activated, decreasing one or more of amplitude, pulse width, pulse frequency, or duration when the EEG indicates at least one of those responses.
EEG-indicated response absent with increased stimulation
Claim 9 covers an implantable nerve stimulator, an EEG recording device, and a controller that determines whether P300 is present or the nucleus basalis or locus coeruleus is activated, increasing one or more of amplitude, pulse width, pulse frequency, or duration when the EEG does not indicate at least one of those responses.
Repeated adjustment based on nucleus basalis or locus coeruleus activation
Claim 10 covers a controller that determines from the EEG whether the nucleus basalis or locus coeruleus is activated and decreases one or more stimulation parameters when activation is indicated, repeatedly adjusting until the stimulation dose is at a level necessary to modulate the patient's inflammatory reflex.
Repeated adjustment with increased stimulation when activation is absent
Claim 17 covers repeated EEG-based determination of whether the nucleus basalis or locus coeruleus is activated, increasing one or more stimulation parameters when activation is absent until the dose is at a level necessary to modulate the patient's inflammatory reflex.
Repeated adjustment to a minimum stimulation dose
Claim 18 covers a controller that repeatedly assesses whether P300 is present or the nucleus basalis or locus coeruleus is activated, adjusting stimulation parameters until the dose is at the minimum level necessary to modulate the patient's inflammatory reflex.
The five independent claims cover EEG-guided adjustment of implantable nerve stimulation, including parameter adjustments based on detected neural activation or P300 markers and repeated tuning to modulate the inflammatory reflex.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Stimulating a patient's nerve, including vagus nerve stimulation, with EEG-based prescreening for vagus nerve stimulation response.
Adjusting the stimulation dose to modulate a patient's inflammatory reflex.
Interested in licensing this patent?